Sanofi inked a deal to co-develop and commercialize oral anti-inflammatory drugs resulting from Recludix Pharma’s STAT6 platform technology. STAT6 (signal transducer and activator of transcription 6), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback